Churg Strauss Syndrome

Clinical Trial for ANCA-Associated Vasculitis – Now Enrolling Patients

Sites throughout the U.S. and Canada are seeking patients with newly diagnosed or relapsed anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.  This clinical trial is designed to determine whether a new non-steroidal treatment, when added to standard of care treatment can improve the remission rate, kidney function, and/or improve vasculitis symptoms.  All…...

Read more

VF Awards $200,000 in Promising New Research

The VF Board of Directors is pleased to announce that it has selected three new research studies for funding this year.  The Vasculitis Foundation collaborates with researchers around the world to fund the most promising studies. The goals of the Research Program are to fund high quality research improve the…...

Read more

2015 V-Red Award Winners Announced

Dr. Sarah Durney of Powell Valley Healthcare in Powell, Wyoming, has been selected as a recipient of the 2015 Vasculitis Foundation’s Recognizing Excellence in Diagnostics (RED) Award. Early diagnosis is critical, and Durney, who loves patient interaction and medical sleuthing, reached a preliminary conclusion in under two weeks for patient…...

Read more

VF Launches Membership Drive

From May 2015 to May 2016, the Vasculitis Foundation is launching a Membership Drive.  And we are asking for your help! We value your membership in the Vasculitis Foundation and we hope that you do too.  As we prepare to celebrate the VF’s 30th Anniversary in 2016, we are asking you…...

Read more

Fellowship Established in Dr. Gary S. Hoffman’s Honor

The Vasculitis Foundation is pleased to announce the 2016 Gary S. Hoffman Vasculitis Foundation Fellowship in honor of Dr. Hoffman, who has had a profound influence on the lives of people with vasculitis and is recognized as a world leader in vasculitis clinical care and research. Upon the announcement of his…...

Read more